The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)

John Mathews; Binglin Yue; Josephine Emole; Taiga Nishihori; Vikas Bhushan; Michael L. Nieder; Frederick L. Locke; Jongphil Kim; Claudio Anasetti; Hugo Fernandez

doi:10.1016/j.bbmt.2014.11.472

The Incidence of Venous Thromboembolism (VTE) in 892 Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients ( A single institution study comparison of VTE incidence with sirolimus versus non-sirolimus-based GVHD prophylaxis)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2014.11.472 ◽

2015 ◽

Vol 21 (2) ◽

pp. S297-S298

Author(s):

John Mathews ◽

Binglin Yue ◽

Josephine Emole ◽

Taiga Nishihori ◽

Vikas Bhushan ◽

...

Keyword(s):

Venous Thromboembolism ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Single Institution ◽

Hematopoietic Cell Transplant ◽

Allogeneic Hematopoietic Cell Transplant ◽

Gvhd Prophylaxis

Download Full-text

Prevalence and Characteristics of Caregiver Distress One-Year after Allogeneic Hematopoietic Cell Transplant in an Older Cohort of Patients - a Single Institution Experience

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.12.177 ◽

2019 ◽

Vol 25 (3) ◽

pp. S77

Author(s):

Theresa A. Elko ◽

Richard J Lin ◽

Ann A. Jakubowski ◽

Miguel-Angel Perales ◽

Molly A. Maloy ◽

...

Keyword(s):

Hematopoietic Cell ◽

Cell Transplant ◽

Caregiver Distress ◽

Single Institution ◽

Hematopoietic Cell Transplant ◽

Allogeneic Hematopoietic Cell Transplant ◽

One Year

Download Full-text

Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis – a single institution experience

Leukemia & Lymphoma ◽

10.1080/10428194.2016.1211280 ◽

2016 ◽

Vol 58 (3) ◽

pp. 740-742 ◽

Cited By ~ 1

Author(s):

Mazyar Shadman ◽

Sangeeta Hingorani ◽

Scott A. Lanum ◽

John M. Pagel ◽

Rainer Storb ◽

...

Keyword(s):

Renal Disease ◽

End Stage Renal Disease ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Single Institution ◽

Hematopoietic Cell Transplant ◽

Allogeneic Hematopoietic Cell Transplant ◽

Stage Renal Disease ◽

End Stage

Download Full-text

Faculty Opinions recommendation of A single center, open-label trial of isavuconazole prophylaxis against invasive fungal infection in patients undergoing allogeneic hematopoietic cell transplant (HCT).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737422328.793571687 ◽

2020 ◽

Author(s):

Livio Pagano

Keyword(s):

Fungal Infection ◽

Invasive Fungal Infection ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Single Center ◽

Hematopoietic Cell Transplant ◽

Open Label ◽

Allogeneic Hematopoietic Cell Transplant ◽

Open Label Trial

Download Full-text

Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2020.05.007 ◽

2020 ◽

Vol 26 (9) ◽

pp. 1597-1606

Author(s):

Gena G. Foster ◽

Michael J. Grant ◽

Samantha M. Thomas ◽

Blake Cameron ◽

Doug Raiff ◽

...

Keyword(s):

Renal Function ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Hematopoietic Cell Transplant ◽

Allogeneic Hematopoietic Cell Transplant

Download Full-text

Prospective Randomized Study of Advance Directives in Allogeneic Hematopoietic Cell Transplant Recipients

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2021.03.030 ◽

2021 ◽

Author(s):

Irena T Tan ◽

Vandana Sundaram ◽

Yvette Ramirez ◽

Sarah Burnash ◽

D. Kate Tierney ◽

...

Keyword(s):

Advance Directives ◽

Randomized Study ◽

Hematopoietic Cell ◽

Prospective Randomized Study ◽

Cell Transplant ◽

Transplant Recipients ◽

Hematopoietic Cell Transplant ◽

Allogeneic Hematopoietic Cell Transplant

Download Full-text

Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00158-5 ◽

2021 ◽

Vol 27 (3) ◽

pp. S124

Author(s):

Issam S. Hamadeh ◽

Michael R. Grunwald ◽

Allison Martin ◽

Jai N. Patel ◽

Alexandra Wolff ◽

...

Keyword(s):

Hematopoietic Cell ◽

Cell Transplant ◽

Transplant Recipients ◽

Hematopoietic Cell Transplant ◽

Allogeneic Hematopoietic Cell Transplant

Download Full-text

Dynamics of Epstein–Barr virus on post‐transplant lymphoproliferative disorders after antithymocyte globulin‐conditioned allogeneic hematopoietic cell transplant

Transplant Infectious Disease ◽

10.1111/tid.13719 ◽

2021 ◽

Author(s):

Julian Lindsay ◽

Jad Othman ◽

Michelle K. Yong ◽

David Ritchie ◽

Lynette Chee ◽

...

Keyword(s):

Antithymocyte Globulin ◽

Epstein Barr Virus ◽

Lymphoproliferative Disorders ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Hematopoietic Cell Transplant ◽

Post Transplant ◽

Allogeneic Hematopoietic Cell Transplant ◽

Barr Virus ◽

Epstein Barr

Download Full-text

Genomic and Proteomic Analysis of Allogeneic Hematopoietic Cell Transplant Outcome. Seeking Greater Understanding the Pathogenesis of GVHD and Mortality

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2008.12.500 ◽

2009 ◽

Vol 15 (1) ◽

pp. e1-e7 ◽

Cited By ~ 3

Author(s):

John A. Hansen

Keyword(s):

Proteomic Analysis ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Hematopoietic Cell Transplant ◽

Transplant Outcome ◽

Allogeneic Hematopoietic Cell Transplant

Download Full-text

Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series

Bone Marrow Transplantation ◽

10.1038/bmt.2009.336 ◽

2010 ◽

Vol 45 (8) ◽

pp. 1357-1359 ◽

Cited By ~ 15

Author(s):

L Anderson ◽

D Gregg ◽

D Margolis ◽

J Casper ◽

J Talano

Keyword(s):

Focal Nodular Hyperplasia ◽

Case Series ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Hematopoietic Cell Transplant ◽

Allogeneic Hematopoietic Cell Transplant ◽

Nodular Hyperplasia

Download Full-text

High Risk Allogeneic Hematopoietic Cell Transplant (HCT) Patients with Any Level of Cytomegalovirus (CMV) Viremia Should Be Treated with Antiviral Therapy to Prevent Serious CMV Disease

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2012.11.463 ◽

2013 ◽

Vol 19 (2) ◽

pp. S312

Author(s):

Lena Winestone ◽

Rajni Agarwal ◽

Kenneth I. Weinberg ◽

Matthew Porteus ◽

Jennifer Reikes Willert ◽

...

Keyword(s):

High Risk ◽

Antiviral Therapy ◽

Hematopoietic Cell ◽

Cell Transplant ◽

Hematopoietic Cell Transplant ◽

Allogeneic Hematopoietic Cell Transplant ◽

Cmv Disease

Download Full-text